CXCR4 and diabetes mellitus: Addition of either of the CXCR4 inhibitors (30 mg/kg for POL5551 and 10 mg/kg for Plerixafor) after the ninth G-CSF dose could rescue diabetes-induced hyporesponsiveness to G-CSF (Figure 2e).